National and Kapodistrian University of Athens
Μελέτη της περιφερικής νευροπάθειας με νευροφυσιολογικές και μικροσκοπικές μεθόδους σε ασθενείς με αμυλοείδωση
Abstract
dc:descriptionAmyloidosis is a rare disease characterized by the deposition of misfolded proteinfibrils in tissues, leading to progressive organ damage. Immunoglobulin light chain(AL) amyloidosis is the most common type of systemic amyloidosis, associated withthe presence of a usually small but ‘dangerous’ plasma cell or lymphocytic clone andthe production of amyloidogenic free light chains (FLCs). At diagnosis, cardiac involvement is common, while other organs that may also be affected include the kidneys, liver, peripheral and autonomic nervous system, soft tissues, and the gastrointestinal tract. The median survival is 55 months. Cardiac involvement is the main adverse prognostic factor, while long-term outcome also largely depends on the characteristics of the underlying plasma cell clone. The autonomic nervous system has also been identified as a negative prognostic factor for survival. The peripheral nervous system (PNS) is often clinically underestimated and requires a more extensive approach for comprehensive evaluation. The aim of this study was the prospective recording and assessment of the significance of neuropathy, and particularly small fiber neuropathy (SFN) with novel neurophysiological methods. Eighty-one newly diagnosed patients who met the diagnostic criteria for AL amyloidosis and the inclusion criteria for our study were consecutively examined using clinical assessment scales (NSS, NIS). They underwent nerve conduction studies, skin biopsy of the distal lower limb, and quantitative sensory testing (QST). Ten of them were re-evaluated 6 to 12 months after diagnosis and initiation of treatment.Our study demonstrated that the PNS was affected in approximately 90% of patients, either clinically or subclinically. The most common form of neuropathy was a symmetric, length-dependent sensory axonal polyneuropathy with concomitant involvement of small fibers small fiber involvement. The types of neuropathies recorded included combinations of large myelinated and small fiber involvement. Pure large fiber involvement was observed in 25% of patients, manifesting as sensory axonal polyneuropathy (16%), sensorimotor axonal polyneuropathy (4%), or carpal tunnelsyndrome (5%). Combined large and small fiber neuropathy was present in 55%, with sensory axonal neuropathy with SFN being the most common type (30%), followed by sensorimotor neuropathy with SFN (15%). Pure SFN was detected in 10%, while 6.2% had SFN in combination with carpal tunnel syndrome. Mixed (axonal anddemyelinating) sensorimotor polyneuropathy with small fiber involvement was present in 4%. Overall, 59% of patients reported positive and negative sensory symptoms and/or neuropathic pain of the extremities, while 42.5% complained of symptoms related to autonomic nervous system dysfunction. Clinical examination frequently revealed impairment of sensation (light touch and pinprick) in a stocking-glove distribution, and to a lesser extent, of vibration. Reduced or absent tendon reflexes were observed in ~30% of patients, whereas ~7% presented with mild distal limb weakness and/or cranial nerve involvement. Almost two-thirds fulfilled the criteria for small fiberinvolvement. Among these, 56% reported paresthesias, one-third experienced neuropathic pain, and a similar proportion had autonomic symptoms. In 10%, SFN was subclinical.The diagnosis of neuropathy in general, and SFN in particular, was more frequent among older patients (p = 0.034 and p = 0.014, respectively). Moreover, SFN was identified as a risk factor for weight loss (OR 3.26, 95% CI: 1.13–9.38, p = 0.028) and was associated with soft tissue involvement (χ² = 7.58, p = 0.006). The presence of neuropathy overall did not emerge as a prognostic factor for mortality and was not correlated to specific cause of death. However, patients who had died exhibited more clinical signs of neuropathy and more frequent symptoms of ANS dysfunction at diagnosis. SFN was associated with reduced overall survival, with pure SFN emerging as an adverse prognostic factor for overall survival compared with other patient groups(those with both small and large fiber involvement, those with only large fiber involvement, and those without neuropathy), retaining its prognostic value in a multivariate analysis including age, dFLC, and Mayo stage (HR: 3, p = 0.036, 95% CI:1.08–8.31). In addition, SFN was an adverse prognostic factor for survival within the first 12 months after diagnosis and treatment initiation, independent of age, cardiac involvement, and Mayo stage (HR = 4.94, 95% CI: 1.26–14.6, p = 0.020). Follow-up evaluation demonstrated significant worsening of clinical findings and NCS results, although small fiber impairment remained stable, as assessed by QST (warm and cold perception thresholds in the lower limb) and skin biopsy (Wilcoxon test p = 0.779, p =0.610, and p = 0.203, respectively). Our study highlighted the high frequency and various forms of neuropathy inAL amyloidosis, its clinical significance, and particularly the prognostic value of SFN in mortality. Therefore, we recommend systematic neurological and neurophysiological assessment in patients with AL amyloidosis, including small fiber neuropathy evaluation using QST and skin biopsy, at initial diagnosis and before treatment initiation. Furthermore, there is evidence that neurological re-evaluation of neuropathy could serve as a marker for monitoring and treatment response, while objective assessments such as QST, skin biopsy, and autonomic testing could be integrated as biomarkers in prognostic models of amyloidosis.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bountziouka, Chrysanthi
- Μπουντζιούκα, Χρυσάνθη
Subjects
dc:subject × 19- AL αμυλοείδωση
- Περιφερική νευροπάθεια
- Βιοψία δέρματος
- Νευροπάθεια λεπτών ινών
- Νευροφυσιολογία
- QST
- AL amyloidosis
- Peripheral neuropathy
- Skin biopsy
- Small fiber neuropathy
- Neurophysiological study
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Κλινική νευρολογία
- Αιματολογία
- Clinical Medicine
- Medical and Health Sciences
- Clinical Neurology
- Hematology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60428